Subjective and objective hearing loss among US adult cancer survivors: A national cross-sectional study.

Qian Wang,Changchuan Jiang,Chi Wen,Hui Xie,Yannan Li,Yaning Zhang,Leila Jean Mady,Debora S. Bruno,Giselle Dutcher,Lauren Chiec,Afshin Dowlati,Melinda Laine Hsu

DOI: https://doi.org/10.1200/jco.2023.41.16_suppl.e24059

IF: 45.3

2023-06-01

Journal of Clinical Oncology

Abstract:e24059 Background: Approximately 13% of adults had some degree of hearing loss (HL), and the prevalence is higher among adults aged 65 and over (30.9%). Approximately 50-80% of the childhood, adolescent and young adult cancer survivor population report HL following treatment with high-dose platinum-based chemotherapy, head or brain radiotherapy. We aimed to 1) estimate the prevalence of subjective and objective hearing loss (HL) among cancer survivors and compare to the general population; 2) assess the performance of subjective HL questions in detecting HL by audiometry among cancer survivors. Methods: Adults aged 20-80 years old were selected from the National Health and Nutrition Examination Survey. The weighted prevalence of subjective HL (having troublesome hearing and tinnitus) and objective HL (speech-frequency HL and high-frequency HL) by audiometry test was calculated. Chi-square test and multi-adjusted logistic regression models were used to compare HL between cancer survivors and the general population. To evaluate the performance of subjective HL questions as a tool to screen for objective HL by audiometry, area under the curve (AUC) were estimated using age-and gender- adjusted logistic regression. Results: Compared to the general population, cancer survivors had a statistically significantly higher prevalence of troublesome hearing ( a OR = 1.43; 95%CI:1.22-1.68), tinnitus ( a OR = 1.28; 95%CI:1.08-1.53), speech-frequency HL (SFHL) ( a OR = 1.44; 95%CI:1.20-1.73) and high-frequency HL (HFHL) ( a OR = 1.74; 95%CI:1.45-2.09). The sensitivity and specificity of the combined subjective questions “whether having troublesome hearing and/or tinnitus” in detecting HL was shown in Table. The age- and gender- adjusted AUC for detecting SFHL and HFHL using combined questions was 0.88 and 0.90. Conclusions: Cancer survivors have a significantly higher prevalence of both subjective and objective HL, but a lack of hearing examination. Two subjective HL questions could accurately identify those have true HL and provide a simple and efficient screening tool for providers. Cancer survivors and their families should be educated and encouraged to discuss hearing concerns, and providers should facilitate raising awareness and provide early screening and timely referral when HL is identified.[Table: see text]

oncology